Markets
Twist Bioscience CEO Emily Leproust Sells $1.79M in Stock: What Traders Need to Know
Twist Bioscience CEO Emily Leproust has sold approximately $1.79 million worth of company stock, a transaction that draws fresh scrutiny to insider sentiment at a pivotal moment for synthetic biology valuations. Here's what the move means mechanically and where TWST goes from here.